SCHEMBL25813650

SCHEMBL25813650

Cc1ccc(-c2c3ccccc3c(-c3ccc(CCI)cc3)c3ccccc23)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 4/20 0.46
▸ ALDH1A1 P00352 4/20 0.45
▸ HPGD P15428 1/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ ALOX12 P18054 1/20 0.45
▸ CASP1 P29466 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ ACHE P22303 1/20 0.44
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ CTDSP1 Q9GZU7 1/20 0.42
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2A6 P11509 1/20 0.41
▸ TAAR1 Q96RJ0 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ PTGS2 P35354 2/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30742831 0.82 ACHE (0.57) ALDH1A1HPGDALOX12ACHEMEN1
SCHEMBL3477351 0.82 ACHE (0.57) ALDH1A1HPGDALOX12ACHEMEN1
SCHEMBL7434377 0.79 CYP1A2 (0.59) ALDH1A1HPGDALOX15ALOX12CASP1
SCHEMBL21224502 0.78 ACHE (0.58) TP53ALDH1A1HPGDALOX12ACHE
SCHEMBL30924193 0.78 ACHE (0.58) TP53ALDH1A1HPGDALOX12ACHE
SCHEMBL7547399 0.77 CYP1A2 (0.56) ALDH1A1HPGDALOX15ALOX12CASP1
SCHEMBL24688385 0.76 ACHE (0.56) ALDH1A1HPGDALOX12ACHEMEN1
SCHEMBL17578343 0.75 TP53 (0.44) TP53ALDH1A1HPGDALOX15HSD17B10
SCHEMBL14224154 0.74 ACHE (0.44) TP53ALDH1A1HSD17B10ACHEMEN1
SCHEMBL3722164 0.73 ACHE (0.48) ALDH1A1HPGDALOX12ACHEMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230189636-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-06-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230189636-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF EMC1, EMC2, EPCAM TP53 2352/4885ALDH1A1 969/4885HPGD 4340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback